1.Chinese expert consensus on ultrasound-guided percutaneous lung needle biopsy (2025 edition)
Society of Ultrasound in Medicine CHINESE ; Physicians Branch of Chinese Medical Doctor Association INTERVENTIONAL ; Of Minimally Invasive Therapy in Oncology, China Anti-Cancer Association SOCIETY ; Branch of Chinese Anti-Tuberculosis Association ULTRASOUND ; Control and Prevention Branch of China International Exchange and Promotive Association for Medical and Health Care TUBERCULOSIS ; Equipment Technology Branch of China Association of Medical Equipment ULTRASOUND ; Sub-Committee of Tuberculosis Branch of Chinese Medical Association ULTRASOUND ; Branch of Shanghai Medical Association ULTRASOUND ; Engineering Research Center of Ultrasound in Diagnosis and Treatment SHANGHAI ; Institute of Medical Imaging SHANGHAI
Chinese Journal of Clinical Medicine 2026;33(2):346-368
Ultrasound-guided percutaneous lung needle biopsy (US-PLNB) is a pivotal diagnostic technique for subpleural pulmonary lesions, offering significant advantages such as real-time imaging, absence of ionizing radiation, and high operational flexibility. To standardize its clinical application and enhance both procedural safety and diagnostic accuracy, a multidisciplinary panel of experts was convened by eleven authoritative Chinese academic societies, including Chinese Society of Ultrasound in Medicine. Based on the latest domestic and international evidence-based medicine, this panel developed Chinese expert consensus on ultrasound-guided percutaneous lung needle biopsy (2025 edition). This consensus systematically elaborates on the indications and contraindications, preprocedural assessment and preparation, intraoperative techniques, complication prevention and management, and post-procedural care for US-PLNB. Furthermore, it puts forward 18 specific evidence-based recommendations. The primary aim of this consensus is to provide radiologists and clinicians with standardized operational guidance, promote the standardized application of US-PLNB, and ultimately improve patient care for individuals with pulmonary diseases.
2.Guideline for the diagnosis and comprehensive treatment of colorectal cancer liver metastases (2025 edition)
College of Surgeons, Chinese Medical Doctor Association CHINESE ; Surgery Group, Chinese Society of Surgery, Chinese Medical Association GASTROINTESTINAL ; Surgery Group, Chinese Society of Surgery, Chinese Medical Association COLORECTAL ; Cancer Professional Committee, Chinese Anti-Cancer Association COLORECTAL ; Cancer Professional Committee, Chinese Medical Doctor Association COLORECTAL ; Cancer Expert Committee, Chinese Society of Clinical Oncology COLORECTAL ; Surgeons Committee, Chinese Congress of Surgeons, Chinese Medical Doctor Association COLORECTAL ; Metastasis Committee, Anorectal Branch of Chinese Medical Doctor Association TUMOR ; Of Colorectal Oncology, Chinese Society of Oncology, Chinese Medical Association SECTION ; Tumor Therapeutics Branch, China International Exchange and Promotive Association for Medical and Health Care METASTATIC ; Disease Branch, China International Exchange and Promotive Association for Medical and Health Care COLORECTAL
Chinese Journal of Clinical Medicine 2026;33(1):160-190
The liver is the primary target organ for hematogenous metastasis of colorectal cancer, and colorectal cancer liver metastasis is one of the key and challenging aspects in its treatment. In order to improve the diagnosis and comprehensive treatment of colorectal cancer liver metastasis in China, the guideline development group has summarized advanced experiences and the latest achievements from both domestic and international sources, and has once again revised and updated the Guideline for the diagnosis and comprehensive treatment of colorectal cancer liver metastases (2025 edition) to continuously provide guidance and reference for clinical practice in this field in China.
3.Expert consensus on pre-hospital emergency management of heatstroke (2024).
EXPERT GROUP ON HEATSTROKE PREVENTION OF PEOPLES' LIBERATION ARMY ; EMERGENCY MEDICINE COMMITTEE OF THE CHINESE AGING WELL ASSOCIATION ; SOCIETY OF EMERGENCY MEDICINE OF THE HAINAN PROVINCIAL MEDICAL ASSOCIATION ; COLLEGE OF EMERGENCY PHYSICIANS OF THE HAINAN PROVINCIAL MEDICAL DOCTOR ASSOCIATION
Chinese Critical Care Medicine 2025;37(1):1-8
Heatstroke, a life-threatening illness, poses a significant risk to human health, particularly in high-temperature and high-humidity environments. Timely and effective on-site management is critical for improving patient survival and prognosis. Rapid recognition, rapid assessment, and rapid cooling are the cornerstones of pre-hospital care. However, the absence of a standardized protocol for pre-hospital management of heatstroke has impeded the efficacy of treatment. This consensus, initiated by the Expert Group on Heatstroke Prevention of the People's Liberation Army, signifies a collaborative endeavor involving emergency medical personnel, nurses, and administrators from pre-hospital care, emergency departments, and intensive care units in both military and civilian domains. By systematically reviewing evidence-based medicine and clinical expertise in heatstroke prevention, on-site and in-transit care, as well as early treatment in emergency settings, the group has formulated the Expert consensus on pre-hospital emergency management of heatstroke (2024) after extensive discussions and iterative recommendations, which serve as a scientific and standardized framework for pre-hospital heatstroke emergency care. The consensus underscores the pivotal role of enhancing public awareness regarding heatstroke prevention and augmenting the rates of rapid recognition and rapid cooling for effective on-site heatstroke management. In high-risk industries, regions, or seasons for heatstroke, developing scientifically sound plans and conducting practical training can provide effective safety measures. Emergency personnel should undergo specialized training and assessments in knowledge and skills, ambulances should be equipped with effective cooling devices, and hospitals must maintain comprehensive emergency response capabilities. It is recommended to establish a regional heatstroke treatment network to optimize the allocation of emergency resources and streamline processes, thereby improving treatment outcomes and response times.
Heat Stroke/prevention & control*
;
Humans
;
Emergency Medical Services
;
Consensus
4.Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024.
Journal of Geriatric Cardiology 2025;22(3):277-331
In the past 6 years, significant breakthroughs have been achieved in the treatment of heart failure (HF), especially in drug therapy. The classification of chronic HF and the treatment methods for HF and its complications are also constantly being updated. In order to apply these results to the diagnosis and treatment of patients with HF in China and further improve the level of diagnosis and treatment of HF in China, the HF Group of Chinese Society of Cardiology, Chinese Medical Association, Chinese College of Cardiovascular Physician, Chinese HF Association of Chinese Medical Doctor Association, and Editorial Board of Chinese Journal of Cardiology have organized an expert group and update the consensus and evidence-based treatment methods in the field of HF based on the latest clinical research findings at home and abroad, combined with the national conditions and clinical practice in China, and referring to the latest foreign HF guidelines while maintaining the basic framework of the 2018 Chinese Guidelines for Diagnosis and Treatment of HF.
5.Expert consensus on technical specifications for interventional nursing of peripheral vascular diseases
China Intravenous Intervention Alliance ; Peripheral Vascular Intervention Professional Committee of the Intervention Physician Branch of Chinese Medical Doctor Association ; Yan LI
Journal of Interventional Radiology 2024;33(6):581-592
In order to provide clinical guidance for standardizing interventional whole-process nursing management and for reducing perioperative complications,this"Expert Consensus on Technical Specifications for Interventional Nursing of Peripheral Vascular Diseases"(hereinafter referred to as the"Consensus")is formulated.Guided by the forefront of specialty development,this"Consensus"systematically searches the relevant literature of domestic and foreign interventional diagnosis and treatment,focusing on the operation steps of interventional diagnosis and treatment technology of peripheral vascular diseases,and,based on evidence-based and clinical practice,this"Consensus"extracts and integrates 6 specialized nursing technologies to form the first draft.Forty-eight experts engaged in the field of vascular intervention nursing care are invited for two rounds of consultations.Based on expert suggestions the"Consensus"has been modified and improved,and the final version is written.The"Consensus"covers six key nursing techniques,each including preoperative assessment and preparation,procedural steps,precautions,health education,prevention and management of common complications,and outcome evaluation.The"Consensus"is characterized by its scientific and practical nature,making it a valuable reference for perioperative clinical nursing practice in interventional diagnosis and treatment of peripheral vascular diseases.(J Intervent Radiol,2024,33:581-592)
6.Chinese expert consensus on the technical specifications for interventional diagnosis and treatment of female pelvic venous disorders
The Expert Working Group on Interventional Gynecology and Children of the Interventional Physician Branch of the Chinese Medical Doctor Association ; Lower Extremity Venous Endovascular Treatment Committee of the Peripheral Vascular Disease Special Committee of the Chinese Microcirculation Society ; Xinwei HAN ; Xin ZHAO ; Yanli WANG
Journal of Interventional Radiology 2024;33(8):821-828
Chronic pelvic pain caused by pelvic venous disorder(PeVD)is a common condition in women.However,clinical physicians'cognition of this disease is not yet comprehensive,so PeVD is easy to be misdiagnosed,thus affecting its treatment.With the development of interventional radiology,the venography and sclerotic agent embolization therapy have gradually become the standard mode for the diagnosis and treatment of this disorder.This consensus focuses on the following aspects:selection of indications,selection of technical methods,intraoperative manipulation,treatment of corresponding complications,gathering the views of domestic multidisciplinary experts engaged in interventional radiology,vascular surgery and medical imaging,clinical management methods,systematical elaboration of the classification and diagnosis of PeVD,and experience in sclerotic agent embolization therapy,aiming to improve the clinical physicians'cognition of PeVD and to promote the standardization of its clinical treatment.
7.Chinese expert consensus on neurosurgical treatment of psychiatric disorders
Chinese Medical Doctor Association Branch of Psychitrists League of Psychosurgery ; Chinese Medical Doctor Association Branch of Neuromodulation ; Yinjie LAN ; Bomin SUN ; Lin LU ; Gaohua WANG ; Wei WANG ; Jianguo ZHANG
Chinese Journal of Nervous and Mental Diseases 2024;50(7):385-402
Chinese expert consensus on neurosurgical treatment of psychiatric disorders is compiled by national experts in neurosurgery,psychiatry,and other related fields.Based on clinical research published up to December 2023 and evidence-based medicine standards,the consensus provides recommendations for neurosurgical treatment of psychiatric disorders.The covered diseases include obsessive-compulsive disorder,depressive disorder,tic disorder,bipolar disorder,anorexia nervosa,substance use-related disorders,and schizophrenia.This expert consensus outlines the safety and efficacy of neurosurgical treatments for psychiatric disorders in clinical practice,and preliminarily standardizes treatment procedures and surgical techniques.The aim is to establish professional standards for the application of surgical treatment techniques for clinical practitioners in the field of psychiatric disorder surgery,thereby maximizing treatment outcomes and promoting the future development of this treatment technology.
8.Expert consensus on integrated traditional Chinese and Western medicine diagnosis and treatment of chronic hepatitis B
Expert Committee on Hepatology,Doctor Society of Integrative Medicine,Chinese Medical Doctor Association ; Xianbo WANG
Journal of Clinical Hepatology 2024;40(5):884-892
Chronic hepatitis B(CHB)is still a major public health issue in China,and without effective control,it can further progress to liver cirrhosis and liver cancer,bringing huge social and economic burdens.At present,antiviral therapy is the main treatment method for CHB,and integrated traditional Chinese and Western medicine therapy is the characteristic treatment method for CHB in China and can improve clinical efficacy by complementing each other's advantages.In order to promote the concept integrated traditional Chinese and Western medicine collaborative diagnosis and treatment,facilitate the development of integrated traditional Chinese and Western medicine diagnosis and treatment techniques for CHB,and establish standardized disease diagnosis and treatment regimens,Expert Committee on Hepatology in Doctor Society of Integrative Medicine,Chinese Medical Doctor Association,established a consensus expert group to discuss and formulate Expert consensus on integrated traditional Chinese and Western medicine diagnosis and treatment of chronic hepatitis B,which elaborated on the concept of integrated traditional Chinese and Western medicine collaborative diagnosis and treatment from the four aspects of CHB epidemiology,pathogenesis and etiology,integrated traditional Chinese and Western medicine diagnosis and syndrome differentiation,and integrated traditional Chinese and Western medicine therapy and proposed related recommendations,in order to improve the prognosis and quality of life of CHB patients.
9.Chinese guideline for diagnosis and treatment of autoimmune pancreatitis(Shanghai,2023)
National Clinical Research Center for Digestive Diseases(Shanghai) ; National Key Laboratory of Immunity and Inflammation ; Professional Committee of Pancreatic Disease,Chinese Medical Doctor Association ; Pancreas Study Group,Society of Gastroenterology,Chinese Medical Association ; Editorial Board of Chinese Journal of Pancreatology ; Zhaoshen LI ; Xun LI ; Xiaozhong GUO ; Zhuan LIAO
Journal of Clinical Hepatology 2024;40(7):1312-1320
Autoimmune pancreatitis(AIP)is an immune-mediated,special type of chronic pancreatitis,which can involve multiple organs.The clinical manifestation of AIP is complex and varied,making the diagnosis and treatment challenging.With reference to the latest guidelines and studies from both domestic and international sources,this guideline comprises 20 recommendations regarding the diagnosis,treatment,follow-up,and prognosis of AIP.The aim of this guideline is to promote the care capability and improve the outcome of patients with AIP in China.
10.Chinese practice guideline for the prevention and treatment of mother-to-child transmission of hepatitis B virus(version 2024)
Infectious Diseases Physicians Branch,Chinese Medical Doctor Association ; Chinese Society of Infectious Diseases,Chinese Medical Association ; Yingren ZHAO ; Lanjuan LI ; Wenhong ZHANG
Journal of Clinical Hepatology 2024;40(8):1557-1566
The 2019 Chinese practice guideline for the prevention and treatment of mother-to-child transmission of hepatitis B virus developed by Chinese Society of Infectious Diseases,Chinese Medical Association,has shown a good guiding effect in standardizing the process for blocking the mother-to-child transmission of hepatitis B virus in China.Clinical practice guidelines and consensus statements require timely updates based on new research evidence,in order to better guide clinical practice and research.Chinese Physician Association for Infectious Diseases,Chinese Medical Doctor Association,and Chinese Society of Infectious Diseases,Chinese Medical Association,cooperated with multidisciplinary experts and performed updates and supplementations to the above guideline,in order to provide guidance and a reference for clinical physicians and medical staff engaged in maternal and child health care.

Result Analysis
Print
Save
E-mail